444 related articles for article (PubMed ID: 33289919)
21. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugs.
Roberts W; Jellison S; Wayant C; Vassar M
BMJ Evid Based Med; 2020 Aug; 25(4):145-146. PubMed ID: 32019896
[TBL] [Abstract][Full Text] [Related]
23. Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey.
Hakoum MB; Anouti S; Al-Gibbawi M; Abou-Jaoude EA; Hasbani DJ; Lopes LC; Agarwal A; Guyatt G; Akl EA
BMJ Open; 2016 Aug; 6(8):e011997. PubMed ID: 27515760
[TBL] [Abstract][Full Text] [Related]
24. Financial conflicts of interest and conclusions about neuraminidase inhibitors for influenza: an analysis of systematic reviews.
Dunn AG; Arachi D; Hudgins J; Tsafnat G; Coiera E; Bourgeois FT
Ann Intern Med; 2014 Oct; 161(7):513-8. PubMed ID: 25285542
[TBL] [Abstract][Full Text] [Related]
25. Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study.
Campsall P; Colizza K; Straus S; Stelfox HT
PLoS Med; 2016 May; 13(5):e1002029. PubMed ID: 27244653
[TBL] [Abstract][Full Text] [Related]
26. Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.
Saldanha IJ; Scherer RW; Rodriguez-Barraquer I; Jampel HD; Dickersin K
Trials; 2016 Apr; 17(1):213. PubMed ID: 27113767
[TBL] [Abstract][Full Text] [Related]
27. Reporting of Financial and Non-financial Conflicts of Interest in Systematic Reviews on Health Policy and Systems Research: A Cross Sectional Survey.
Bou-Karroum L; Hakoum MB; Hammoud MZ; Khamis AM; Al-Gibbawi M; Badour S; Justina Hasbani D; Cruz Lopes L; El-Rayess HM; El-Jardali F; Guyatt G; Akl EA
Int J Health Policy Manag; 2018 Aug; 7(8):711-717. PubMed ID: 30078291
[TBL] [Abstract][Full Text] [Related]
28. Financial Conflicts of Interest Among Authors of Clinical Practice Guidelines for Routine Screening Mammography.
Combs T; Tritz D; Ivy H; von Borstel D; Horn J; Vassar M
J Am Coll Radiol; 2019 Nov; 16(11):1598-1603. PubMed ID: 31152689
[TBL] [Abstract][Full Text] [Related]
29. Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings.
Hayes MJ; Prasad V
Hastings Cent Rep; 2018 Mar; 48(2):10-13. PubMed ID: 29590518
[TBL] [Abstract][Full Text] [Related]
30. [Conflicts of interest in scientific advisory panels].
Kullberg BJ; Geleijnse M
Ned Tijdschr Geneeskd; 2022 Oct; 166():. PubMed ID: 36300497
[TBL] [Abstract][Full Text] [Related]
31. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
Choudhry NK; Stelfox HT; Detsky AS
JAMA; 2002 Feb; 287(5):612-7. PubMed ID: 11829700
[TBL] [Abstract][Full Text] [Related]
32. Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.
Norris SL; Holmer HK; Ogden LA; Burda BU; Fu R
PLoS One; 2013; 8(10):e75284. PubMed ID: 24155870
[TBL] [Abstract][Full Text] [Related]
33. Association between author conflicts of interest and industry-sponsorship with the favorability of outcomes of systematic reviews focusing on treatments of erectile dysfunction.
Corcoran A; Hillman C; Cole T; Anderson M; Weaver M; Johnson BS; Hartwell M; Vassar M
Andrology; 2021 Nov; 9(6):1819-1827. PubMed ID: 34173351
[TBL] [Abstract][Full Text] [Related]
34. Financial ties between DSM-IV panel members and the pharmaceutical industry.
Cosgrove L; Krimsky S; Vijayaraghavan M; Schneider L
Psychother Psychosom; 2006; 75(3):154-60. PubMed ID: 16636630
[TBL] [Abstract][Full Text] [Related]
35. Localization techniques for guided surgical excision of non-palpable breast lesions.
Chan BK; Wiseberg-Firtell JA; Jois RH; Jensen K; Audisio RA
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009206. PubMed ID: 26718728
[TBL] [Abstract][Full Text] [Related]
36. Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories.
Moynihan R; Lai A; Jarvis H; Duggan G; Goodrick S; Beller E; Bero L
BMJ Open; 2019 Feb; 9(2):e025864. PubMed ID: 30813119
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.
Neuman J; Korenstein D; Ross JS; Keyhani S
BMJ; 2011 Oct; 343():d5621. PubMed ID: 21990257
[TBL] [Abstract][Full Text] [Related]
38. Financial Conflicts of Interest Among Authors of Urology Clinical Practice Guidelines.
Carlisle A; Bowers A; Wayant C; Meyer C; Vassar M
Eur Urol; 2018 Sep; 74(3):348-354. PubMed ID: 29747945
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
